COMMUNIQUÉS West-GlobeNewswire

Healthcare’s Financial Leaders Pledge Unprecedented Collaboration to Address America’s Healthcare Affordability Crisis
21/10/2026
‘Declaration on Healthcare Affordability and Sustainability’ offers a results-oriented roadmap toward innovative, data-driven solutions CHICAGO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management [...]
Organic & Natural Health Association Shares 5 Ways Americans Can Protect Their Health as Insurance Costs Rise
21/10/2026
WASHINGTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- As Americans prepare for another year of rising health insurance costs, staying healthy is becoming a financial concern as well as a personal priority. With Affordable Care [...]
P-Protect Introduces P-Protect Patch - A New Patch-Based Option for Men’s Prostate Wellness
21/10/2026
P-Protect Patch is a men's wellness product that brings prostate health awareness, ingredient transparency, responsible use, and informed healthcare decisions into the conversation. New York, Oct. 21, 2026 (GLOBE [...]
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
21/10/2026
MALVERN, Pa., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook [...]
TaiMed Biologics Reports IDWeek 2026 Data Highlighting TMB-365 and Its Potential Across Long-Acting HIV Combinations
21/10/2026
Phase 1 results demonstrate TMB-365 antiviral activity and tolerability, supporting continued development as a differentiated antibody for combination HIV treatment Complementary laboratory susceptibility findings [...]
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
21/10/2026
-- Preclinical study demonstrates positive effects of sotagliflozin on cardiac function and structure in hypertrophic cardiomyopathy -- -- Second preclinical study shows inhibitory effects of sotagliflozin on platelet [...]
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
21/10/2026
Shareholder Special Meeting Scheduled for November 19, 2026 Definitive proxy statement filed with the SEC, marking an important milestone toward completion of the proposed transaction HeartSciences Board of Directors [...]
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
21/10/2026
Nearly one in three adults who were still smoking or vaping after a prior ORCA trial had quit at the end of a year of cytisinicline treatment, with quit rates rising through the year Among the participants new to [...]
10X Health Launches Metabolism Genetic Test
21/10/2026
A saliva-based test provides genetic insights to help inform personalized nutrition and weight-management plans SCOTTSDALE, Ariz., Oct. 21, 2026 (GLOBE NEWSWIRE) -- 10X Health , a leader in personalized health [...]
Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company
21/10/2026
Chairman-led transaction marks the first step in a broader series of actions to provide a more flexible framework to support the Company's commercial plans HAIFA, Israel, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. ( [...]
IMUNON Announces Strategic Sale of ThermoDox®
21/10/2026
Agreement with VoxelDox Therapeutics, Inc. Creates a Clear Path to Future Value, Subject to Achievement of Development Milestones in the Planned Phase 1 Glioblastoma Trial Sale Reinforces IMUNON's Commitment to Its Core [...]
Onicor Appoints Antifungal Pioneer Piet De Doncker, PhD, as CEO to Advance Personalized Treatment for Fungal Nail Infections
21/10/2026
Developer of itraconazole pulse therapy to lead Onicor's personalized nail orthosis for onychomycosis, a common and hard-to-treat condition, into its next phase TILBURG, the Netherlands, 21 October 2026 – Onicor , a [...]
Santa Ana Bio to Present Preclinical Data on SAB05, a CD40-Targeted Glucocorticoid Antibody-Drug Conjugate, at ACR Convergence 2026
21/10/2026
ALAMEDA, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Santa Ana Bio, a clinical-stage precision immunology company, today announced that preclinical data on SAB05, its CD40-targeted glucocorticoid antibody-drug conjugate ( [...]
VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling
21/10/2026
Patient-derived liver and intestinal disease models are designed to help drug developers test whether a candidate reduces human disease in tissue before it reaches clinical trials SAN DIEGO, Oct. 21, 2026 (GLOBE [...]
Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
21/10/2026
- Robin Swartz, Voyager’s Chief Business and Operating Officer, appointed President, effective immediately; expected to succeed Alfred W. Sandrock, Jr., M.D., Ph.D., as CEO in Q1 2027 - - Dr. Sandrock expected to remain [...]
PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
21/10/2026
Analysis demonstrates a lower bacterial burden in breakthrough surgical-site infections, with similar proportions of multidrug-resistant organisms between treatment groups PETACH TIKVA, Israel, Oct. 21, 2026 (GLOBE [...]
Hyro’s new brand identity champions Agentic Care Communications, rallying the healthcare industry around delivering Care OnCue™
21/10/2026
New brand identity centers on agentic adoption at scale, orchestrating staff, systems, and workflows around patient access, IT service management, revenue cycle, and clinical support, so care reaches patients in the [...]
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
21/10/2026
FOSTER CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today [...]
Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses
21/10/2026
Seven presentations include pediatric Phase 4 studies of AZSTARYS® (Serdexmethylphenidate/dexmethylphenidate) CII and real-world research of JORNAY PM® (Delayed-Release/Extended-Release Methylphenidate) CII in adults [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum